Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
Smith
A Y
AY
Department of Surgery, University of Texas Medical School, Houston 77030.
Citterio
F
F
Welsh
M
M
Kerman
R H
RH
Kahan
B D
BD
D015415:Biomarkers / Q000097:blood*; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004261:DNA Replication / Q000187:drug effects; D003937:Diagnosis, Differential; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000097:blood*; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000276:immunology*; D016030:Kidney Transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D012016:Reference Values
D015415:Biomarkers; D003524:Cyclosporins; D007376:Interleukin-2; D015375:Receptors, Interleukin-2